Shaw and Partners and Morgans seek to raise for Soul Patts-backed opiate grower News17 Oct 2019

Palla Pharma boss Jarrod Ritchie stands in a field of poppy flowers near Cressy in Northern Tasmania.

 

Listed opiate grower Palla Pharma, the company formerly known as TPI Enterprises, was in the market on Thursday, seeking to raise $31.1 million by way of a placement and rights issue.

 

Shaw and Partners and Morgans Financial launched the fully underwritten deal to new and existing investors, offering shares in Palla at 70¢ each. The offer price reflected a 15 per cent discount to the theoretical ex-rights price.

 

It is understood major shareholders Washington H. Soul Pattinson, Alex Waislitz’s Thorney Opportunities Group and Simon Moore, Colinton Capital founder and the former country head of private equity giant Carlyle Investments, will participate in the raising.

 

Palla Pharma shares were placed in a trading halt on Thursday. The stock last traded at 90¢.

 

The Jarrod Ritchie-led company plans to use the new funds for growth capital to expand production capacity, and to reduce debt.

 

Unlike rival Tasmanian Alkaloids which produces cannabis resin, Palla Pharma is sticking to opiates and its hard-fought-for strategy as a pharmaceuticals manufacturer.

 

The $72 million company, which listed as TPI in 2015, is fully vertically integrated from the poppy farm to the pharmacy. Its attraction to investors has been that it has developed a process that manufactures product significantly cheaper than its competitors.

 

Palla’s tech uses water to make opiate pills and needs just 50-60 people to make 80 tonnes of product a year, compared to 100-150 people.

 

It's one of just three growers and processors in the country and the only one that operates outside of Tasmania.

 

Article source: AFR, 17 October 2019

Related Articles
News18 Nov 2019 Shaw and Partners takes on new sponsorship of the North Bondi Surf Life Saving Club Surf Rowing Boats
Shaw and Partners is pleased to extend its sponsorship of the North Bondi Surf Life Saving Club Youth Division by taking on an additional sponsorship of the club’s Surf Rowing Boat... Read More
News12 Nov 2019 Shaw and Partners appointed as Joint Lead Manager to the IPO of Happy Valley Nutrition
Shaw and Partners is pleased to be appointed as Joint Lead Manager to the proposed IPO of Happy Valley Nutrition Limited.   The company is seeking to raise up to $15.0m at $0.20 ... Read More
News01 Nov 2019 Shaw and Partners hosts the Equity Market Outlook "Investing in a world with low interest rates" event in Melbourne
Shaw and Partners was pleased to host the Equity Market Outlook "Investing in a world with low interest rates" event at the Grand Hyatt in Melbourne last night.   Over 170 attend... Read More
News31 Oct 2019 Shaw and Partners Equity Market Outlook continues in Sydney at the MCAS
Yesterday evening we continued our national Equity Market Outlook presentation, hosting 300 clients and prospects at the Museum of Contemporary Art in Sydney.   Shaw and Partners... Read More
A - Z  % Change  
{{data.Symbol}} {{data.CompanyName}} {{data.Close}} {{data.AsAt | date :'shortTime'}} {{data.Movement | number : 2}} {{data.MovementPercent | number: 2}}%